Haydar Çelik

674 total citations
27 papers, 447 citations indexed

About

Haydar Çelik is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Haydar Çelik has authored 27 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 5 papers in Neurology. Recurrent topics in Haydar Çelik's work include Neurofibromatosis and Schwannoma Cases (5 papers), Acute Myeloid Leukemia Research (4 papers) and Signaling Pathways in Disease (4 papers). Haydar Çelik is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (5 papers), Acute Myeloid Leukemia Research (4 papers) and Signaling Pathways in Disease (4 papers). Haydar Çelik collaborates with scholars based in United States, Türkiye and Mexico. Haydar Çelik's co-authors include Emel Arınç, Müberra Koşar, Aykut Üren, Jeffrey A. Toretsky, Jenny Han, Tsion Z. Minas, Yasemin Saygıdeğer, Hayriye V. Erkizan, K. Kav and Michelle A. Rudek and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Haydar Çelik

23 papers receiving 436 citations

Peers

Countries citing papers authored by Haydar Çelik

Since Specialization

Citations

This map shows the geographic impact of Haydar Çelik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haydar Çelik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haydar Çelik more than expected).

Fields of papers citing papers by Haydar Çelik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haydar Çelik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haydar Çelik. The network helps show where Haydar Çelik may publish in the future.

Co-authorship network of co-authors of Haydar Çelik

This figure shows the co-authorship network connecting the top 25 collaborators of Haydar Çelik. A scholar is included among the top collaborators of Haydar Çelik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haydar Çelik. Haydar Çelik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells 2021 ·PLoS ONE ·(unknown), Haydar Çelik, (unknown), (unknown), (unknown), (unknown), Garrett T. Graham, (unknown), Jeffrey A. Toretsky, Aykut Üren	5
2	Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia 2020 ·Blood Advances ·Haydar Çelik, Katherine E. Lindblad, Bogdan Popescu, Gege Gui, Meghali Goswami, Janet Valdez, Christin B. DeStefano, Catherine Lai, Julie Thompson, Jack Ghannam, Giovanna Fantoni, Angélique Biancotto, Julián Candia, Foo Cheung, Gauthaman Sukumar, Clifton L. Dalgard, Richard H. Smith, André Larochelle, Laura W. Dillon, Christopher S. Hourigan	38
3	A Novel Proteomic Profiling of the Bone Marrow Microenvironment Reveals Elevated Levels of the Chemokine CCL23 Isoforms in Acute Myeloid Leukemia 2019 ·Blood ·Haydar Çelik, Katherine E. Lindblad, Bogdan Popescu, Giovanna Fantoni, Gege Gui, Janet Valdez, Meghali Goswami, Christin B. DeStefano, Catherine Lai, Angélique Biancotto, Julián Candia, Foo Cheung, Julie Thompson, Jack Ghannam, Gauthaman Sukumar, Richard H. Smith, Clifton L. Dalgard, André Larochelle, Laura W. Dillon, Christopher S. Hourigan	0
4	Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99 2018 ·Oncogene ·Haydar Çelik, Marika Sciandra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jenny Han, (unknown), Purushottam B. Tiwari, Mutlu Hayran, Brent T. Harris, Maria Cristina Manara, Jeffrey A. Toretsky, Katia Scotlandi, Aykut Üren	25
5	Abstract 1933: Discovery of first-in-class small molecule CD99 inhibitors for targeted therapy of Ewing sarcoma 2017 ·Cancer Research ·Haydar Çelik, Marika Sciandra, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jenny Han, (unknown), Purushottam B. Tiwari, Mutlu Hayran, Maria Cristina Manara, Jeffrey A. Toretsky, Katia Scotlandi, Aykut Üren	1
6	Ezrin Inhibition Up-regulates Stress Response Gene Expression 2016 ·Journal of Biological Chemistry ·Haydar Çelik, Gülay Bulut, Jenny Han, Garrett T. Graham, Tsion Z. Minas, (unknown), (unknown), Gary T. Pauly, Mutlu Hayran, Xin Li, Metin Özdemirli, A. Ayhan, Michelle A. Rudek, Jeffrey A. Toretsky, Aykut Üren	43
7	Ezrin Enhances EGFR Signaling and Modulates Erlotinib Sensitivity in Non–Small Cell Lung Cancer Cells 2016 ·Neoplasia ·Yasemin Saygıdeğer, Tsion Z. Minas, (unknown), (unknown), Haydar Çelik, (unknown), Jenny Han, Neşe Atabey, Hayriye V. Erkizan, Jeffrey A. Toretsky, Aykut Üren	31
8	Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box 2015 ·Molecular Cancer Therapeutics ·Haydar Çelik, (unknown), Daisy D. Colón-López, Jenny Han, Yasemin Saygıdeğer, Tsion Z. Minas, Matthew Swift, Mikell Paige, Eric Glasgow, Jeffrey A. Toretsky, Jürgen Bosch, Aykut Üren	17
9	YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model 2015 ·Oncotarget ·Tsion Z. Minas, Jenny Han, Tahereh Javaheri, (unknown), Michaela Schlederer, Yasemin Saygıdeğer, Haydar Çelik, Kristina M. Mueller, (unknown), Metin Özdemirli, Heinrich Kovar, Hayriye V. Erkizan, Jeffrey A. Toretsky, Lukas Kenner, Richard Moriggl, Aykut Üren	19
10	Abstract 54: Ezrin enhances signaling and nuclear translocation of the epidermal growth factor receptor in non-small cell lung cancer cells 2015 ·Cancer Research ·Yasemin Saygıdeğer, Haydar Çelik, Hayriye V. Erkizan, Tsion Z. Minas, Jenny Han, Jeffrey A. Toretsky, Aykut Üren	0
11	Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level 2015 ·Molecular and Cellular Biology ·Haydar Çelik, Kamal P. Sajwan, Saravana P. Selvanathan, (unknown), (unknown), Yasemin Saygıdeğer, Jenny Han, Tsion Z. Minas, Said Rahim, Hayriye V. Erkizan, Jeffrey A. Toretsky, Aykut Üren	30
12	Human papillomavirus type 16 E7 oncoprotein upregulates the retinoic acid receptor-beta expression in cervical cancer cell lines and K14E7 transgenic mice 2015 ·Molecular and Cellular Biochemistry ·(unknown), Enrique García‐Villa, Rodolfo Ocadiz‐Delgado, (unknown), (unknown), (unknown), (unknown), Haydar Çelik, Marta Romano, Aykut Üren, Paul F. Lambert, Patricio Gariglio	7
13	Antiedema effects of proanthocyanidin on experimental traumatic brain edema 2015 ·Turkish Neurosurgery ·Yavuz Erdem, (unknown), (unknown), (unknown), Haydar Çelik, Ali Erdem Yıldırım, (unknown), Mehmet Akif Bayar	3
14	A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model 2014 ·PLoS ONE ·Said Rahim, Tsion Z. Minas, (unknown), (unknown), Haydar Çelik, Yasemin Saygıdeğer, Jenny Han, Abraham T. Kallarakal, Yali Kong, Michelle A. Rudek, Milton L. Brown, Bhaskar Kallakury, Jeffrey A. Toretsky, Aykut Üren	43
15	In vitro effects of myricetin, morin, apigenin, (+)-taxifolin, (+)-catechin, (−)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 reductase 2013 ·Toxicology ·Haydar Çelik, Müberra Koşar, Emel Arınç	10
16	Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue 2013 ·Virology ·(unknown), (unknown), José Díaz‐Chávez, Alfredo Hidalgo‐Miranda, Sandra Romero‐Córdoba, Aykut Üren, Haydar Çelik, (unknown), (unknown), (unknown), (unknown), Paul F. Lambert, Daniel Mendoza-Villanueva, Rosa María Bermúdez‐Cruz, Patricio Gariglio	27
17	Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4 2012 ·Xenobiotica ·Haydar Çelik, Emel Arınç	3
18	Inhibitory effects of dietary flavonoids on purified hepatic NADH-cytochrome b5 reductase: Structure–activity relationships 2012 ·Chemico-Biological Interactions ·Haydar Çelik, Müberra Koşar	41
19	Inhibition mechanisms of lead, cadmium and nickel for the purified bovine liver NADPH-cytochrome P450 reductase 2011 ·Toxicology Letters ·Azra Bozcaarmutlu, Haydar Çelik, Emel Arınç	0
20	Identification and antimicrobial susceptibility of subclinical mastitis pathogens isolated from hair goats' milk. 2009 ·Journal of Animal and Veterinary Advances ·İbrahim Aydın, K. Kav, Haydar Çelik	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact